Dr. Reddy's Laboratories Limited RDY
NYSE
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 795.16M | 861.19M | 936.52M | 919.12M | 785.88M |
| Total Receivables | 1.06B | 1.07B | 1.08B | 1.16B | 1.13B |
| Inventory | 846.68M | 851.10M | 816.19M | 879.28M | 853.53M |
| Prepaid Expenses | 25.13M | 27.41M | 22.13M | 22.87M | 25.68M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 372.85M | 355.91M | 361.45M | 330.77M | 349.43M |
| Total Current Assets | 3.10B | 3.17B | 3.22B | 3.31B | 3.15B |
|
|
|||||
| Total Current Assets | 3.10B | 3.17B | 3.22B | 3.31B | 3.15B |
| Net Property, Plant & Equipment | 1.20B | 1.22B | 1.24B | 1.29B | 1.26B |
| Long-term Investments | 135.37M | 136.01M | 137.50M | 138.11M | 138.44M |
| Goodwill | 135.37M | 136.01M | 137.50M | 138.11M | 138.44M |
| Total Other Intangibles | 1.09B | 1.10B | 1.12B | 1.14B | 1.14B |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 295.87M | 297.01M | 289.24M | 279.66M | 309.59M |
| Total Assets | 5.99B | 6.08B | 6.18B | 6.26B | 6.10B |
|
|
|||||
| Total Accounts Payable | 376.31M | 396.58M | 238.49M | 454.01M | 453.08M |
| Total Accrued Expenses | 401.26M | 387.61M | 506.17M | 424.69M | 436.50M |
| Short-term Debt | 607.62M | 610.12M | 630.66M | 559.62M | 463.29M |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 24.34M | 25.17M | 64.02M | 64.97M | 64.69M |
| Total Finance Division Other Current Liabilities | 201.72M | 244.60M | 347.71M | 258.51M | 281.45M |
| Total Other Current Liabilities | 201.72M | 244.60M | 347.71M | 258.51M | 281.45M |
| Total Current Liabilities | 1.61B | 1.66B | 1.79B | 1.76B | 1.70B |
|
|
|||||
| Total Current Liabilities | 1.61B | 1.66B | 1.79B | 1.76B | 1.70B |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | 607.62M | 610.12M | 630.66M | 559.62M | 463.29M |
| Capital Leases | 121.95M | 125.69M | 130.14M | 129.18M | 131.00M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 197.40M | 204.60M | 203.91M | 191.69M | 195.41M |
| Total Liabilities | 1.93B | 1.99B | 2.12B | 2.08B | 2.03B |
|
|
|||||
| Common Stock & APIC | 128.43M | 130.02M | 130.10M | 135.39M | 136.72M |
| Retained Earnings | 3.74B | 3.77B | 3.75B | 3.89B | 3.80B |
| Treasury Stock & Other | 154.98M | 155.63M | 137.36M | 115.93M | 97.50M |
| Total Common Equity | 4.03B | 4.06B | 4.02B | 4.14B | 4.04B |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 4.03B | 4.06B | 4.02B | 4.14B | 4.04B |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | 33.28M | 34.98M | 36.20M | 37.73M | 40.45M |
| Total Equity | 4.06B | 4.09B | 4.06B | 4.18B | 4.08B |
|
|
|||||